The Good News: the “proof that puts an end to the SARS-COV-2 narrative” The Bad And Ugly News is about A Second Or Subsequent Booster Shot, inclosing The Professors outlines his Preferred Option concerning COVID-19 and Vaccines Continue Reading
Evidence-based Medicine Consultancy Ltd and EbMC Squared CiC Director Dr. Tess Lawrie (MBBCh, PhD), says “The MHRA now has more than enough evidence on the Yellow Card system to declare the COVID-19 vaccines unsafe for use in humans. Preparation should be made to scale up humanitarian efforts to assist those harmed by the COVID-19 vaccines and to anticipate and ameliorate medium to longer term effects.” Continue Reading
The U.S. Department of Defense is supporting creation of a small, portable device that safely sends vaccines and therapies through the skin. The device is being developed by Inovio Pharmaceuticals Inc. in Plymouth Meeting, Pennsylvania, and funded by an $8.14 million award from DoD’s Medical CBRN Defense Consortium; CBRN stands for Chemical, Biological, Radiological, and Nuclear threats. Continue Reading
Until now, local inflammation and scar tissue from the so-called “foreign body response” has prevented the development of in-body sensors capable of continuous, long-term monitoring of body chemistry. But today scientists are presenting results showing tiny biosensors that become one with the body have overcome this barrier, and stream data to a mobile phone and to the cloud for personal and medical use. Continue Reading
Broadly defined, transfection is the process of artificially introducing nucleic acids (DNA or RNA) into cells, utilizing means other than viral infection. Such introductions of foreign nucleic acid using various chemical, biological, or physical methods can result in a change of the properties of the cell, allowing the study of gene function and protein expression in the context of the cell. Continue Reading
AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful by most of the countries with which it has struck supply agreements, a senior executive told Reuters. With 25 companies testing their vaccine candidates on humans and getting ready to immunise hundred millions of people once the products are shown to work, the question of who pays for any claims for damages in case of side effects has been a tricky point in supply negotiations. Continue Reading
It has been amply demonstrated, that electroporation augments uptake of DNA in both skin and muscle, and it is foreseen that future DNA vaccination may to a large extent be coupled with and dependent upon electroporation based delivery. Continue Reading
“These positive preclinical results from our COVID-19 DNA vaccine (INO-4800) not only highlight the potency of our DNA medicines platform, but also build on our previously reported positive Phase 1/2a data from our vaccine against the coronavirus that causes MERS, which demonstrated near-100% seroconversion and neutralization from a similarly designed vaccine INO-4700. The potent neutralizing antibody and T cell immune responses generated in multiple animal models are supportive of our currently on-going INO-4800 clinical trials.” Continue Reading
But before release into commerce, genetically modified crops are first assessed for possible risk, including risks to the environment. Potential environmental risks associated with gene flow, risks associated with the allergy or toxic to human being, beneficial insects or non target organisms, risk associated with directly switching transgenic plants to superweeds, risk associated with increasing use of herbicides and the pest resistant to Bt plant are the major concern of the day. Continue Reading
ill Gates suggests approx. 4:26 minutes into the speech; Population needs to be addressed as part of the contribution towards achieving Zero CO2 Bill gates said “if we do a really great job on New Vaccines, Health Care, Reproductive Health Services, we could lower that by perhaps 10-15% Continue Reading